Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
44 Results Found
ACT NOW: Urge Your Members of Congress to Protect Medicaid and Other Crucial Programs
Congressional committees have begun marking up their portions of a reconciliation bill to enact key pieces of President Trump’s agenda.
TAKE ACTION: Urge Lawmakers to Reject Medicaid Cuts, Protect Access to Care
With your senators and representatives home in their states and districts for the next two weeks, please reach out to your lawmakers and urge them to reject funding cuts to Medicaid and other health care programs as part of reconciliation bill.
AHA, others file amicus briefs opposing major drug companies’ 340B rebate models
The AHA has filed a number of friend-of-the-court briefs in cases before the U.S. District Court for the District of Columbia, urging the court to uphold the Health Resources and Services Administration’s decision to reject drug companies’ proposed 340B rebate models in separate lawsuits brought by a number of drug companies to bar the agency from doing so.
340B AHA Advocacy Alliance - March 7, 2025
AHA, others file amicus briefs opposing major drug companies’ 340B rebate models
Hospitals That Have Committed to the 340B Principles
To ensure good stewardship of the 340B program, hospitals participating in the program should structure hospital policies and practices to demonstrate their commitment. That demonstration of commitment includes sharing publicly how 340B savings are used to benefit the community, by, for example reaching more eligible patients and providing more comprehensive services for those in the community. The following hospitals have taken that commitment.
HRSA directs Sanofi to cease implementing unapproved 340B rebate proposal
The Health Resources and Services Administration last week directed Sanofi to cease implementation of its 340B rebate proposal immediately and to inform HRSA of its plans no later than Dec. 20 in order to provide adequate notice to covered entities.
The Future of Health System-Based Cancer Care
Costly innovative cancer treatments and technologies, organizational alignments and shifting sites of care are changing the way care is delivered.
HRSA responds to AHA outreach regarding Johnson & Johnson’s unilateral imposition of 340B rebate model
Johnson & Johnson announced Aug. 23 that it would be fundamentally changing the way it makes 340B pricing available for two of its most popular products, Stelara and Xarelto.
AHA 340B Advocacy Alliance
J&J announces major change to 340B pricing; HRSA responds to preemptive AHA advocacy.
AHA, others file briefs in Maryland, West Virginia to prevent injunctions against 340B pricing for contract pharmacy arrangements
The AHA, 340B Health, Maryland Hospital Association and Mid-Atlantic Association of Community Health Centers July 9 filed an amicus brief in a federal district court in Maryland, defending the state’s law protecting 340B pricing for contract pharmacy arrangements.